A randomised phase II multicentre study of ipilimumab with temozolomide vs temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblastoma: Ipi-Glio

Mulholland PJ., Brown NF., McBain C., Brazil L., Peoples S., Jefferies S., Harris F., Plaha P., Vinayan A., Brooks C., Hussain S., Dutton SJ., Ng S., Levy S., Coutts T.

DOI

10.1200/jco.2023.41.17_suppl.lba2023

Type

Journal article

Journal

Journal of clinical oncology

Publisher

American Society of Clinical Oncology

Publication Date

07/06/2023

Volume

41

Keywords

clinical research, rare diseases, brain disorders, clinical trials and supportive activities, genetics, cancer, brain cancer

Permalink Original publication